FindTrial
Sign In

The Use of Lactated Ringer’s solution as a carrier for del Nido Cardioplegia

The Use of Lactated Ringer’s solution as a carrier for del Nido Cardioplegia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180124002
Enrollment
Unknown
Registered
2018-01-24
Start date
2017-02-06
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Could Lactated Ringer’s solution be safely used for del Nido cardioplegia with comparable clinical outcomes? del Nido cardioplegia &#44

Interventions

Patient undergoing cardiac surgery with del Nido cardioplegia,Patient undergoing cardiac surgery with blood cardioplegia
Experimental Drug,Active Comparator Drug
del Nido cardioplegia,Blood cardioplegia

Sponsors

Ramathibodi Hospital
Lead Sponsor
Mahidol University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient undergoing adult cardiac surgery

Exclusion criteria

Exclusion criteria: Lidocaine allergy

Design outcomes

Primary

MeasureTime frame
Myocardial preservation post op day 0,1,2 Troponin-T , CK and CK-MB levels—

Secondary

MeasureTime frame
Clinical outcomes before discharge from hospital ICU stays, Hospital stays, complications—

Countries

Thailand

Contacts

Public ContactNarongrit Kantathut

Ramathibodi Hospital

narongrit.kan@mahidol.ac.th081-515-1152

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026